SCHEMBL31248947

SCHEMBL31248947

CC(C)(C)OC(=O)NCc1ccc(-c2ccnc(-c3ccc(OCc4ccccc4)nc3OCc3ccccc3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 3/20 0.45
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ACACB O00763 1/20 0.41
▸ ACACA Q13085 1/20 0.41
▸ NTSR1 P30989 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ GPR55 Q9Y2T6 1/20 0.40
▸ AKT1 P31749 1/20 0.40
▸ HPN P05981 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ TDP1 Q9NUW8 3/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NAMPT P43490 3/20 0.38
▸ PSMB1 P20618 1/20 0.38
▸ PSMB8 P28062 1/20 0.38
▸ PSMB9 P28065 1/20 0.38
▸ PSMB5 P28074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31248643 0.90 HDAC1 (0.43) HDAC1MEN1KMT2AACACBACACA
SCHEMBL25079220 0.85 HDAC1 (0.52) HDAC1MEN1KMT2ANTSR1POLB
SCHEMBL31248684 0.83 MEN1 (0.42) HDAC1MEN1KMT2ANTSR1POLB
SCHEMBL25079170 0.82 HDAC1 (0.45) HDAC1MEN1KMT2ANTSR1POLB
SCHEMBL31467422 0.78 CYP2C9 (0.42) MEN1KMT2A
SCHEMBL31248912 0.78 HDAC1 (0.50) HDAC1MEN1KMT2AACACBACACA
SCHEMBL2566299 0.74 HDAC1 (0.58) HDAC1MEN1KMT2APSMB1PSMB8
SCHEMBL30817313 0.74 CA12 (0.48) MEN1KMT2AMAPTKDM4E
SCHEMBL31467423 0.74 GRIN2B (0.43) HDAC1MEN1KMT2AAKT1
SCHEMBL31467426 0.74 GRIN2B (0.43) HDAC1MEN1KMT2AAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720057-A2 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2026-04-08 — — EP disclosed
WO-2024249888-A2 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) 2024-12-05 — — WO disclosed
Send feedback